Global Therapeutic Report on Erythropoietin Stimulating Agents [2015]

Dec 24 2015 Mumbai, India: Bharatbook.com announces a report on “Global Therapeutic Report on Erythropoietin Stimulating Agents [2015] ”. The market for erythropoietin in Asia-Pacific and South America is expected to grow at the fastest rate compared to other global markets, which are expected to decline.

The global market for erythropoietin stimulating agents with a compound annual growth rate (CAGR) of 0.2% for the period 2015-2020.

This report provides:

-An overview of the global markets and therapeutic applications for erythropoietin stimulating agents (ESAs).

-Analyses of U.S. as well as international market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.

-Coverage of the market in value terms broken down by major types of erythropoietin, by major regions, and by applications.

-Coverage of applications including cancer therapy, chronic kidney disease (CKD) therapy, HIV therapy, and anemia therapy.

-Major trends and challenges affecting the market and the supplier landscape.

-A look at industrial developments and the advent of biosimilars impacting the market.

-Analysis of the risks associated with the market for abusive uses of ESAa and their adverse effects.

-Profiles of major players in the industry.

INTRODUCTION

The global market for erythropoietin drug can be broadly classified into two segments: biologics and biosimilars.

The major types of biologic erythropoietin drugs based on different biological properties are epoetin-alfa, epoetin-beta, darbepoetin-alfa and epoetin-theta.

The major types of biosimilar erythropoietin drug based on the different biological properties are epoetin-zeta, epoetin-omega, epoetin-lambda and epoetin-delta.

The global erythropoietin biologics drug market has been growing in terms of value from the past 15 years in pace with the increasing prevalence of chronic kidney diseases throughout the world, however the market is expected to see decline in the...